A 94-year-old female with history of hypertension, chronic kidney disease, and hyperlipidemia presents to the emergency ...
Background: Cardiovascular disease caused by atherosclerosis is responsible for 18 million deaths annually, highlighting a significant need for new medical therapies, especially for patients who are ...
Background: Transthyretin amyloidosis with cardiomyopathy (ATTR-CM) is a progressive disease caused by the deposition of transthyretin as amyloid in the myocardium. Current therapies may slow disease ...
Abstracts From the American Heart Association's 2025 Scientific Sessions and the American Heart Association's 2025 Resuscitation Science Symposium ...
Background: Chronic insomnia affects up to one-third of adults, and over-the-counter melatonin is increasingly promoted as a “cardiometabolic-friendly” sleep aid. Robust data on its long-term ...
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are ...
Background: Cardiac allograft vasculopathy (CAV) is an important cause of mortality after heart transplantation (HT). Dyslipidemia is a major contributor to the development of CAV. The safety and ...
The action of two pure veratrum alkaloids, veratridine and protoveratrine, in human hypertension is described for the first time. The vasodepressor reflex pathway involved in the response to these ...